Stock listing
Axogen, Inc.
Selected listing: 0HKD · LSE · USD · GB
Axogen, Inc. (LSE:0HKD), Health Technology. Latest release Oct 1, 2026: Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First…

- Ticker
- LSE:0HKD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSE
- Currency
- USD
Latest news from Axogen, Inc.
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
October 1, 2026
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
September 10, 2026
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
September 10, 2026
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
September 1, 2026
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology
July 29, 2026
Events
Research Axogen, Inc.
Alternate listings
AXGN:NASDAQ
US · USD
Alternate listing for Axogen, Inc.; the primary context on this page is 0HKD:LSE.
AXGN:BOATS
US · USD
Alternate listing for Axogen, Inc.; the primary context on this page is 0HKD:LSE.
A1JMHK:LS
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is 0HKD:LSE.
LT3:FWB
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is 0HKD:LSE.
LT3:TRADEGATE
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is 0HKD:LSE.
LT3:SWB
DE · EUR
Alternate listing for Axogen, Inc.; the primary context on this page is 0HKD:LSE.